The role of growth hormone in T-cell development and reconstitution

Journal of Leukocyte Biology

Volumn 71, Issue 3, 2002, Pages 381-387

  Welniak, Lisbeth A ^a   Sun, Rui ^a   Murphy, William J ^a  

^a SAIC FREDERICK INC   (United States)

Author keywords

Deficiency; Dwarf; Neuroendocrine hormones; Thymus

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

CELL MATURATION; HORMONE ACTION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; LYMPHOCYTE FUNCTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ANIMALS; CELL DIFFERENTIATION; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; RATS; RECEPTORS, SOMATOTROPIN; T-LYMPHOCYTES; THYMUS GLAND;

EID: 0036521465     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Smith, P. (1930) The effect of hypophysectomy upon the involution of the thymus in the rat. Anat. Rec. 47, 119-143.
2. Berczi, I., Nagy, E., Kovacs, K., Horvath, E. (1981) Regulation of humoral immunity in rats by pituitary hormones. Acta Endocrinol. 98, 506-513.
3. Nagy, E., Berczi, I., Friesen, H. (1983) Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinol. 102, 351-357.
4. Murphy, W., Durum, S., Anver, M., Longo, D. (1992) Immunologic and hematologic effects of neuroendocrine hormones. Studies on DW/J dwarf mice. J. Immunol. 148, 3799-3805.
5. Murphy, W., Durum, S., Longo, D. (1992) Role of neuroendocrine hormones in murine T cell development. Growth hormone exerts thymopoietic effects in vivo. J. Immunol. 149, 3851-3857.
6. Wallis, M. (1992) The expanding growth hormone/prolactin family. J. Mol. Endocrinol. 9, 185-188.
7. Baumann, G., Stolar, M. W., Buchanan, T. A. (1986) The metabolic clearance, distribution, and degradation of dimeric and monomeric growth hormone (GH): implications for the pattern of circulating GH forms. Endocrinology 119, 1497-1501.
8. Kelly, P., Ali, S., Rozakis, M., Goujon, L., Nagano, M., Pellegrini, I., Gould, D., Djiane, J., Edery, M., Finidori, J., et al. (1993) The growth hormone/prolactin receptor family. Recent Prog. Horm. Res. 48, 123-164.
9. Wells, J. A., de Vos, A. M. (1993) Structure and function of human growth hormone: implications for the hematopoietins. Annu. Rev. Biophys. Biomol. Struct. 22, 329-351.
10. Hattori, N., Shimatsu, A., Sugita, M., Kumagai, S., Imura, H. (1990) Immunoreactive growth hormone (GH) secretion by human lymphocytes: augmented release by exogenous GH. Biochem. Biophys. Res. Commun. 168, 396-401.
11. Varma, S., Sabharwal, P., Sheridan, J. F., Malarkey, W. B. (1993) Growth hormone secretion by human peripheral blood mononuclear cells detected by an enzyme-linked immunoplaque assay. J. Clin. Endocrinol. Metab. 76, 49-53.
12. Weigent, D. A., Baxter, J. B., Wear, W. E., Smith, L. R., Bost, K. L., Blalock, J. E. (1988) Production of immunoreactive growth hormone by mononuclear leukocytes. FASEB J. 2, 2812-2818.
13. Weigent, D. A., Blalock, J. E. (1990) Immunoreactive growth hormone-releasing hormone in rat]eukocytes. J. Neuroimmunol. 29, 1-13.
14. Hattori, N., Saito, T., Yagyu, T., Jiang, B. H., Kitagawa, K., Inagaki, C. (2001) GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J. Clin. Endocrinol. Metab. 86, 4284-4291.
15. Fain, J. N., Kovacev, V. P., Scow, R. O. (1965) Effect of growth hormone and dexamethasone on lipolysis and metabolism in isolated fat cells of the rat. J. Biol. Chem. 240, 3522-3529.
16. Kostyo, J. L. (1968) Rapid effects of growth hormone on amino acid transport and protein synthesis. Ann. N. Y. Acad. Sci. 148, 389-407.
17. Kleinberg, D. L., Todd, J. (1980) Evidence that human growth hormone is a potent lactogen in primates. J. Clin. Endocrinol. Metab. 51, 1009-1013.
18. Somers, W., Ultsch, M., De Vos, A. M., Kossiakoff, A. A. (1994) The X-ray structure of a growth hormone-prolactin receptor complex. Nature 372, 478-481.
19. Cunningham, B. C., Bass, S., Fuh, G., Wells, J. A. (1990) Zinc mediation of the binding of human growth hormone to the human prolactin receptor. Science 250, 1709-1712.
20. Fu, Y. K., Arkins, S., Fuh, G., Cunningham, B. C., Wells, J. A., Fong, S., Cronin, M. J., Dantzer, R., Kelley, K. W. (1992) Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor. J. Clin. Investig. 89, 451-457.
21. Colosi, P., Wong, K., Leong, S. R., Wood, W. I. (1993) Mutational analysis of the intracellular domain of the human growth hormone receptor. J. Biol. Chem. 268, 12617-12623.
22. Argetsinger, L. S., Campbell, G. S., Yang, X., Witthuhn, B. A., Silvennoinen, O., Ihle, J. N., Carter-Su, C. (1993) Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase. Cell 74, 237-244.
23. Gagnerault, M., Postel-Vinay, M., Dardenne, M. (1996) Expression of growth hormone receptors in murine lymphoid cells analyzed by flow cytofluorometry. Endocrinology 137, 1719-1726.
24. Dardenne, M., Mello-Coelho, V., Gagnerault, M. C., Postel-Vinay, M. C. (1998) Growth hormone receptors and immunocompetent cells. Ann. N. Y. Acad. Sci. 840, 510-517.
25. Thellin, O., Coumans, B., Zorzi, W., Barnard, R., Hennen, G., Heinen, E., Igout, A. (1998) Expression of growth hormone receptors by lymphocyte subpopulations in the human tonsil. Dev. Immunol. 6, 295-304.
26. Span, J. P., Pieters, G. F., Smals, A. G., Koopmans, P. P., Kloppenborg, P. W. (1996) Number and percentage of NK-cells are decreased in growth hormone-deficient adults. Clin. Immunol. Immunopathol. 78, 90-92.
27. Kiess, W., Malozowski, S., Gelato, M., Butenand, O., Doerr, H., Crisp, B., Eisl, E., Maluish, A., Belohradsky, B. H. (1988) Lymphocyte subset distribution and natural killer activity in growth hormone deficiency before and during short-term treatment with growth hormone releasing hormone. Clin. Immunol. Immunopathol. 48, 85-94.
28. Yakar, S., Liu, J. L., Stannard, B., Butler, A., Accili, D., Sauer, B., LeRoith, D. (1999) Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc. Natl. Acad. Sci. USA 96, 7324-7329.
29. Rajaram, S., Baylink, D. J., Mohan, S. (1997) Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocr. Rev. 18, 801-831.
30. Geffner, M. E., Bersch, N., Lippe, B. M., Rosenfeld, R. G., Hintz, R. L., Golde, D. W. (1990) Growth hormone mediates the growth of T-lymphoblast cell lines via locally generated insulin-like growth factor-I. J. Clin. Endocrinol. Metab. 71, 464-469.
31. Baxter, J. B., Blalock, J. E., Weigent, D. A. (1991) Characterization of immunoreactive insulin-like growth factor-I from leukocytes and its regulation by growth hormone. Endocrinology 129, 1727-1734.
32. Kirstein, M., Aston, C., Hintz, R., Vlassara, H. (1992) Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins. J. Clin. Investig. 90, 439-446.
33. Arkins, S., Rebeiz, N., Biragyn, A., Reese, D. L., Kelley, K. W. (1993) Murine macrophages express abundant insulin-like growth factor-I class I Ea and Eb transcripts. Endocrinology 133, 2334-2343.
34. Lin, B., Kinoshita, Y., Hato, F., Tsuji, Y. (1997) Enhancement of thymic lymphocyte proliferation by the culture supernatant of thymus epithelial cells stimulated by prolactin. Cell. Mol. Biol. (Noisy-Le-Grand) 43, 361-367.
35. Tsuji, Y., Kinoshita, Y., Hato, F., Tominaga, K., Yoshida, K. (1994) The in vitro proliferation of thymus epithelial cells stimulated with growth hormone and insulin-like growth factor-I. Cell. Mol. Biol. (Noisy-LeGrand) 40, 1135-1142.
36. Timsit, J., Savino, W., Safieh, B., Chanson, P., Gagnerault, M. C., Bach, J. F., Dardenne, M. (1992) Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. J. Clin. Endocrinol. Metab. 75, 183-188.
37. Gronthos, S., Simmons, P. J. (1995) The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. Blood 85, 929-940.
38. Landreth, K. S., Narayanan, R., Dorshkind, K. (1992) Insulin-like growth factor-I regulates pro-B cell differentiation. Blood 80, 1207-1212.
39. Thomas, T., Gori, F., Spelsberg, T. C., Khosla, S., Riggs, B. L., Conover, C. A. (1999) Response of bipotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes. Endocrinology 140, 5036-5044.
40. LeRoith, D., Werner, H., Beitner-Johnson, D., Roberts Jr., C. T. (1995) Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr. Rev. 16, 143-163.
41. Nissley, P., Lopaczynski, W. (1991) Insulin-like growth factor receptors. Growth Factors 5, 29-43.
42. Kooijman, R., Willems, M., De Haas, C. J., Rijkers, G. T., Schuurmans, A. L., Van Buul-Offers, S. C., Heijnen, C. J., Zegers, B. J. (1992) Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells. Endocrinology 131, 2244-2250.
43. Polychronakos, C., Guyda, H. J., Posner, B. I. (1983) Receptors for the insulin-like growth factors on human erythrocytes. J. Clin. Endocrinol. Metab. 57, 436-438.
44. Catanese, V. M., Grigorescu, F., King, G. L., Kahn, C. R. (1986) The human erythrocyte insulin-like growth factor I receptor: characterization and demonstration of ligand-stimulated autophosphorylation. J. Clin. Endocrinol. Metab. 62, 692-699.
45. Stuart, C. A., Meehan, R. T., Neale, L. S., Cintron, N. M., Furlanetto, R. W. (1991) Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes. J. Clin. Endocrinol. Metab. 72, 1117-1122.
46. Kozak, R. W., Haskell, J. F., Greenstein, L. A., Rechler, M. M., Waldmann, T. A., Nissley, S. P. (1987) Type I and II insulin-like growth factor receptors on human phytohemagglutinin-activated T lymphocytes. Cell. Immunol. 109, 318-331.
47. Tapson, V. F., Boni-Schnetzler, M., Pilch, P. F., Center, D. M., Berman, J. S. (1988) Structural and functional characterization of the human T lymphocyte receptor for insulin-like growth factor I in vitro. J. Clin. Investig. 82, 950-957.
48. Kooijman, R., Willems, M., Rijkers, G. T., Brinkman, A., van Buul-Offers, S. C., Heijnen, C. J., Zegers, B. J. (1992) Effects of insulin-like growth factors and growth hormone on the in vitro proliferation of T lymphocytes. J. Neuroimmunol. 38, 95-104.
49. Kooijman, R., Scholtens, L. E., Rijkers, G. T., Zegers, B. J. (1995) Type I insulin-like growth factor receptor expression in different developmental stages of human thymocytes. J. Endocrinol. 147, 203-209.
50. Montecino-Rodriguez, E., Clark, R., Dorshkind, K. (1998) Effects of insulin-like growth factor administration and bone marrow transplantation on thymopoiesis in aged mice. Endocrinology 139, 4120-4126.
51. Kimata, H., Yoshida, A. (1994) Differential effect of growth hormone and insulin-like growth factor-I, insulin-like growth factor-II, and insulin on Ig production and growth in human plasma cells. Blood 83, 1569-1574.
52. Kimata, H., Fujimoto, M. (1994) Growth hormone and insulin-like growth factor I induce immunoglobulin (Ig)E and IgG4 production by human B cells. J. Exp. Med. 180, 727-732.
53. Stephenson, J. R., Lee, J. M., Bailey, N., Shepherd, A. G., Melling, J. (1991) Adjuvant effect of human growth hormone with an inactivated flavivirus vaccine. J. Infect. Dis. 164, 188-191.
54. Gaytan, F., Romero, J. L., Bellido, C., Morales, C., Reymundo, C., Aguilar, E. (1994) Effects of growth hormone and prolactin on testicular macrophages in long-term hypophysectomized rats. J. Reprod. Immunol. 27, 73-84.
55. Edwards III, C. K., Ghiasuddin, S. M., Yunger, L. M., Lorence, R. M., Arkins, S., Dantzer, R., Kelley, K. W. (1992) In vivo administration of recombinant growth hormone or gamma interferon activities macrophages: enhanced resistance to experimental Salmonella typhimurium infection is correlated with generation of reactive oxygen intermediates. Infect. Immun. 60, 2514-2521.
56. Edwards III, C. K., Lorence, R. M., Dunham, D. M., Arkins, S., Yunger, L. M., Greager, J. A., Walter, R. J., Dantzer, R., Kelley, K. W. (1991) Hypophysectomy inhibits the synthesis of tumor necrosis factor alpha by rat macrophages: partial restoration by exogenous growth hormone or interferon gamma. Endocrinology 128, 989-999.
57. Wiedermann, C. J., Reinisch, N., Braunsteiner, H. (1993) Stimulation of monocyte chemotaxis by human growth hormone and its deactivation by somatostatin. Blood 82, 954-960.
58. Edwards III, C. K., Arkins, S., Yunger, L. M., Blum, A., Dantzer, R., Kelley, K. W. (1992) The macrophage-activating properties of growth hormone. Cell. Mol. Neurobiol. 12, 499-510.
59. Oberholtzer, E., Contarini, M., Veglia, F., Cossarizza, A., Franceschi, C., Geuna, M., Provinciali, M., Di Stefano, G., Sissom, J., Brizzi, M. F., Pegoraro, L., Matera, L. (1996) Prolactin increases the susceptibility of primary leukemia cells to NK and LAK effectors. Adv. Neuroimmunol. 6, 233-247.
60. Gertler, A., Cohen, N., Maoz, A. (1983) Human growth hormone but not ovine or bovine growth hormones exhibits galactopoietic prolactin-like activity in organ culture from bovine lactating mammary gland. Mol. Cell. Endocrinol. 33, 169-182.
61. Gibson, L. F., Piktel, D., Landreth, K. S. (1993) Insulin-like growth factor-1 potentiates expansion of interleukin-7-dependent pro-B cells. Blood 82, 3005-3011.
62. Snow, E. C., Feldbush, T. L., Oaks, J. A. (1981) The effect of growth hormone and insulin upon MLC responses and the generation of cytotoxic lymphocytes. J. Immunol. 126, 161-164.
63. Duquesnoy, R. J. (1975) The pituitary dwarf mouse: a model for study of endocrine immunodeficiency disease. Birth Defects Orig. Artic. Ser. 11, 536-543.
64. Sornson, M. W., Wu, W., Dasen, J. S., Flynn, S. E., Norman, D. J., O'Connell, S. M., Gukovsky, I., Carriere, C., Ryan, A. K., Miller, A. P., Zuo, L., Gleiberman, A. S., Andersen, B., Beamer, W. G., Rosenfeld, M. G. (1996) Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384, 327-333.
65. Li, S., Crenshaw III, E. B., Rawson, E. J., Simmons, D. M., Swanson, L. W., Rosenfeld, M. G. (1990) Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347, 528-533.
66. Camper, S. A., Saunders, T. L., Katz, R. W., Reeves, R. H. (1990) The Pit-1 transcription factor gene is a candidate for the murine Snell dwarf mutation. Genomics 8, 586-590.
67. Dumont, F., Robert, F., Bischoff, P. (1979) T and B lymphocytes in pituitary dwarf Snell-Bagg mice. Immunology 38, 23-31.
68. Schneider, G. B. (1976) Immunological competence in Snell-Bagg pituitary dwarf mice: response to the contact-sensitizing agent oxazolone. Am. J. Anat. 145, 371-393.
69. Montecino-Rodriguez, E., Clark, R. G., Powell-Braxton, L., Dorshkind, K. (1997) Primary B cell development is impaired in mice with defects of the pituitary/thyroid axis. J. Immunol. 159, 2712-2719.
70. Dorshkind, K., Horseman, N. D. (2000) The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr. Rev. 21, 292-312.
71. Montecino-Rodriquez, E., Clark, R., Johnson, A., Collinis, L., Dorshkind, K. (1996) Defective B cell development in Snell dwarf (dw/dw) mice can be corrected by thyroxine treatment. J. Immunol. 157, 3334-3340.
72. Cross, R. J., Bryson, J. S., Roszman, T. L. (1992) Immunologic disparity in the hypopituitary dwarf mouse. J. Immunol. 148, 1347-1352.
73. Murphy, W. J., Longo, D. L. (2000) Growth hormone as an immunomodulating therapeutic agent. Immunol. Today 21, 211-213.
74. Flurkey, K., Papaconstantinou, J., Miller, R. A., Harrison, D. E. (2001) Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl. Acad. Sci. USA 98, 6736-6741.
75. Dobashi, H., Sato, M., Tanaka, T., Tokuda, M., Ishida, T. (2001) Growth hormone restores glucocorticoid-induced T cell suppression. FASEB J. 15, 1861-1863.
76. Minshall, C., Arkins, S., Freund, G. G., Kelley, K. W. (1996) Requirement for phosphatidylinositol 3′-kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J. Immunol. 156, 939-947.
77. Kelley, K. W., Meier, W. A., Minshall, C., Schacher, D. H., Liu, Q., VanHoy, R., Burgess, W., Dantzer, R. (1998) Insulin growth factor-I inhibits apoptosis in hematopoietic progenitor cells. Implications in thymic aging. Ann. N. Y. Acad. Sci. 840, 518-524.
78. Roldan, A., Charreau, E., Schillaci, R., Eugui, E. M., Allison, A. C. (1989) Insulin-like growth factor-1 increases the mitogenic response of human peripheral blood lymphocytes to phytohemagglutinin. Immunol. Lett. 20, 5-8.
79. Mercola, K. E., Cline, M. J., Golde, D. W. (1981) Growth hormone stimulation of normal and leukemic human T-lymphocyte proliferation in vitro. Blood 58, 337-340.
80. Taub, D., Tsarfaty, G., Lloyd, A., Durum, S., Longo, D., Murphy, W. (1994) Growth hormone promotes human T cell adhesion and migration to both human and murine matrix proteins in vitro and directly promotes xenogeneic engraftment. J. Clin. Investig. 94, 293-300.
81. Matera, L., Galetto, A., Geuna, M., Vekemans, K., Ricotti, E., Contarini, M., Moro, F., Basso, G. (2000) Individual and combined effect of granulocyte-macrophage colony-stimulating factor and prolactin on maturation of dendritic cells from blood monocytes under serum-free conditions. Immunology 100, 29-36.
82. Edwards III, C. K., Yunger, L. M., Lorence, R. M., Dantzer, R., Kelley, K. W. (1991) The pituitary gland is required for protection against lethal effects of Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 88, 2274-2277.
83. Edwards, C.K. III, Ghiasuddin, S. M., Schepper, J. M., Yunger, L. M., Kelley, K. W. (1988) A newly defined property of somatotropin: priming of macrophages for production of superoxide anion. Science 239, 769-771.
84. Murphy, W., Durum, S., Longo, D. (1993) Differential effects of growth hormone and prolactin on murine T cell development and function. J. Exp. Med. 178, 231-236.
85. Gaufo, G. O., Diamond, M. C. (1996) Prolactin increases CD4/CD8 cell ratio in thymus-grafted congenitally athymic nude mice. Proc. Natl. Acad. Sci. USA 93, 4165-4169.
86. Clevenger, C. V., Russell, D. H., Appasamy, P. M., Prystowsky, M. B. (1990) Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin. Proc. Natl. Acad. Sci. USA 87, 6460-6464.
87. Hartmann, D. P., Holaday, J. W., Bernton, E. W. (1989) Inhibition of lymphocyte proliferation by antibodies to prolactin. FASEB J. 3, 2194-2202.
88. Murphy, W., Durum, S., Anver, M., Frazier, M., Longo, D. (1992) Recombinant human growth hormone promotes human lymphocyte engraftment in immunodeficient mice and results in an increased incidence of human Epstein Barr virus-induced B-cell lymphoma. Brain Behav. Immun. 6, 355-364.
89. Tian, Z. G., Woody, M. A., Sun, R., Welniak, L. A., Raziuddin, A., Funakoshi, S., Tsarfaty, G., Longo, D. L., Murphy, W. J. (1998) Recombinant human growth hormone promotes hematopoietic reconstitution after syngeneic bone marrow transplantation in mice. Stem Cells 16, 193-199.
90. Tsarfaty, G., Longo, D., Murphy, W. (1994) Human insulin-like growth factor I exerts hematopoietic growth-promoting effects after in vivo administration. Exp. Hematol. 22, 1273-1277.
91. Woody, M. A., Welniak, L. A., Sun, R., Tian, Z. G., Henry, M., Richards, S., Raziuddin, A., Longo, D. L., Murphy, W. J. (1999) Prolactin exerts hematopoietic growth-promoting effects in vivo and partially counteracts myelosuppression by azidothymidine. Exp. Hematol. 27, 811-816.
92. Woody, M. A., Welniak, L. A., Richards, S., Taub, D. D., Tian, Z., Sun, R., Longo, D. L., Murphy, W. J. (1999) Use of neuroendocrine hormones to promote reconstitution after bone marrow transplantation. Neuroimmunomodulation 6, 69-80.